Device Trial Radar · NCT03474874
Human Repeated Insult Patch Test
Last checked: Nov 19, 2026Latest source record: Jul 16, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
68
Actual
Start
Feb 26, 2018
Primary completion
Apr 6, 2018
Study completion Apr 6, 2018
Sponsor
- Lead sponsor
- NeXtGen Biologics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 23, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 79 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Repeated insult patch test on healthy males and females to determine potential contact irritation or contact allergy in the skin
Conditions
- Dermatitis
- Allergy
- Contact Allergy
Interventions
NeoMatriX Collagen DressingDevice
Collagen wound dressing
Primary outcomes
What the sponsor says the trial is designed to measure.
- Erythema at the Patch Test Site is Evaluated for Each ParticipantTime frame: 3 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Consumer Product Testing Company, Inc.
Fairfield, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.